v3.24.1.1.u2
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 262,000 $ 2,578,000
Prepaid expenses and other current assets 1,210,000 299,000
Income tax receivable 313,000 183,000
Total current assets 1,785,000 3,060,000
Other non-current assets 8,742,000 8,742,000
Total assets 10,527,000 11,802,000
Current liabilities:    
Accounts payable 8,506,000 9,939,000
Accrued expenses 979,000 1,141,000
Accrued interest payable 34,000 238,000
Debt, current portion 1,000,000 1,000,000
Total current liabilities 10,519,000 12,318,000
Debt, net of current portion 3,194,000 4,194,000
Total non-current liabilities 3,194,000 4,194,000
Total liabilities 13,713,000 16,512,000
Stockholders' deficit:    
Preferred stock, $0.001 par value; 10,000,000 authorized; no shares issued or outstanding as of March 31, 2024 and December 31, 2023 0 0
Common stock, $0.001 par value; 100,000,000 authorized; 4,854,931 and 480,095 issued as of March 31, 2024 and December 31, 2023 respectively; 4,854,861 and 480,025 shares outstanding as of March 31, 2024 and December 31, 2023, respectively 5,000 0
Treasury Stock at cost; 70 shares at both of March 31, 2024 and December 31, 2023 (1,000) (1,000)
Additional paid-in capital 128,223,000 120,043,000
Accumulated deficit (132,617,000) (125,497,000)
Accumulated comprehensive income 1,204,000 745,000
Total stockholders' deficit (3,186,000) (4,710,000)
Total liabilities and stockholders' deficit $ 10,527,000 $ 11,802,000